Ryan J Sullivan (Ryan Sullivan)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 85

Top Topics

Combination Therapy

Top Venues

Journal for immunotherapy of cancer

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications 4 (5) (2024)
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, Julie Simon, Aikaterini Dedeilia, Sydney Ch'ng, Robyn P M Saw, Andrew J Spillane, Kerwin F Shannon, Thomas E Pennington, Michael Rtshiladze, Jonathan R Stretch, Omgo E Nieweg, Alexander C J van Akkooi, Ryan J Sullivan, Genevieve Marie Boland, Jeffrey E Gershenwald, Paul J van Diest, Richard A Scolyer, Georgina V Long, John F Thompson, Serigne N Lô
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Meghan J Mooradian, Florian J Fintelmann, Thomas J LaSalle, Judit Simon, Alexander Graur, Alona Muzikansky, Mari Mino-Kenudson, Sophia Z Shalhout, Howard L Kaufman, Russell William Jenkins, Donald Lawrence, Aleigha Lawless, Tatyana Sharova, Raul N Uppot, Jacy Fang, Emily M Blaum, Anna L K Gonye, Irena Gushterova, Genevieve Marie Boland, Christopher Azzoli, Nir Hacohen, Moshe Sade-Feldman, Ryan J Sullivan
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial. Nature communications 15 (1) (2024)
Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner, Amina Bougrine, Leeann Burton, Laura C Cappelli, Mariana Castells, Justine Cohen, Anna K Dewan, Riley Fadden, Lauren Guggina, Aparna Hegde, Victor Huang, Douglas B Johnson, Benjamin Kaffenberger, Daniela Kroshinsky, Shawn Kwatra, Bernice Kwong, Mario E Lacouture, Cecilia Larocca, Jonathan Leventhal, Alina Markova, Jon McDunn, Meghan J Mooradian, Jarushka Naidoo, Jennifer Choi, Vinod Nambudiri, Caroline A Nelson, Anisha B Patel, Julia Pimkina, Johnathan Rine, Krista M Rubin, Maxwell Sauder, Sheila Shaigany, Afreen Shariff, Ryan J Sullivan, Leyre Zubiri, Kerry Lynn Reynolds, Nicole R LeBoeuf
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy. Journal for immunotherapy of cancer 12 (4) (2024)
Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner, Amina Bougrine, Leeann Burton, Laura C Cappelli, Mariana Castells, Justine Cohen, Anna K Dewan, Riley Fadden, Lauren Guggina, Aparna Hegde, Victor Huang, Douglas B Johnson, Benjamin Kaffenberger, Daniela Kroshinsky, Shawn Kwatra, Bernice Kwong, Mario E Lacouture, Cecilia Larocca, Jonathan Leventhal, Alina Markova, Jon McDunn, Meghan J Mooradian, Jarushka Naidoo, Jennifer Choi, Vinod Nambudiri, Caroline A Nelson, Anisha B Patel, Julia Pimkina, Johnathan Rine, Krista M Rubin, Maxwell Sauder, Sheila Shaigany, Afreen Shariff, Ryan J Sullivan, Leyre Zubiri, Kerry Lynn Reynolds, Nicole R LeBoeuf
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy. Journal for immunotherapy of cancer 12 (4) (2024)
Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery (2024)
Molly Fisher Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep, Pritha Sen, Nandini Samanta, Jessica Tantivit, Mazen Nasrallah, Leyre Zubiri, Neal P Smith, Alice Tirard, Swetha Ramesh, Benjamin Y Arnold, Linda T Nieman, Jonathan H Chen, Thomas Eisenhaure, Karin Pelka, Yuhui Song, Katherine H Xu, Vjola Jorgji, Christopher J Pinto, Tatyana Sharova, Rachel Glasser, PuiYee Chan, Ryan J Sullivan, Hamed Khalili, Dejan Juric, Genevieve Marie Boland, Michael Dougan, Nir Hacohen, Bo Li, Kerry L Reynolds, Alexandra-Chloé Villani
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis. Nature medicine 30 (5) (2024)
Meghan J Mooradian, Florian J Fintelmann, Thomas J LaSalle, Judit Simon, Alexander Graur, Alona Muzikansky, Mari Mino-Kenudson, Sophia Z Shalhout, Howard L Kaufman, Russell William Jenkins, Donald Lawrence, Aleigha Lawless, Tatyana Sharova, Raul N Uppot, Jacy Fang, Emily M Blaum, Anna L K Gonye, Irena Gushterova, Genevieve Marie Boland, Christopher Azzoli, Nir Hacohen, Moshe Sade-Feldman, Ryan J Sullivan
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial. Nature communications 15 (1) (2024)
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, Julie Simon, Aikaterini Dedeilia, Sydney Ch'ng, Robyn P M Saw, Andrew J Spillane, Kerwin F Shannon, Thomas E Pennington, Michael Rtshiladze, Jonathan R Stretch, Omgo E Nieweg, Alexander C J van Akkooi, Ryan J Sullivan, Genevieve Marie Boland, Jeffrey E Gershenwald, Paul J van Diest, Richard A Scolyer, Georgina V Long, John F Thompson, Serigne N Lô
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Meghan J Mooradian, Florian J Fintelmann, Thomas J LaSalle, Judit Simon, Alexander Graur, Alona Muzikansky, Mari Mino-Kenudson, Sophia Z Shalhout, Howard L Kaufman, Russell William Jenkins, Donald Lawrence, Aleigha Lawless, Tatyana Sharova, Raul N Uppot, Jacy Fang, Emily M Blaum, Anna L K Gonye, Irena Gushterova, Genevieve Marie Boland, Christopher Azzoli, Nir Hacohen, Moshe Sade-Feldman, Ryan J Sullivan
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial. Nature communications 15 (1) (2024)
Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner, Amina Bougrine, Leeann Burton, Laura C Cappelli, Mariana Castells, Justine Cohen, Anna K Dewan, Riley Fadden, Lauren Guggina, Aparna Hegde, Victor Huang, Douglas B Johnson, Benjamin Kaffenberger, Daniela Kroshinsky, Shawn Kwatra, Bernice Kwong, Mario E Lacouture, Cecilia Larocca, Jonathan Leventhal, Alina Markova, Jon McDunn, Meghan J Mooradian, Jarushka Naidoo, Jennifer Choi, Vinod Nambudiri, Caroline A Nelson, Anisha B Patel, Julia Pimkina, Johnathan Rine, Krista M Rubin, Maxwell Sauder, Sheila Shaigany, Afreen Shariff, Ryan J Sullivan, Leyre Zubiri, Kerry Lynn Reynolds, Nicole R LeBoeuf
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy. Journal for immunotherapy of cancer 12 (4) (2024)
Molly Fisher Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep, Pritha Sen, Nandini Samanta, Jessica Tantivit, Mazen Nasrallah, Leyre Zubiri, Neal P Smith, Alice Tirard, Swetha Ramesh, Benjamin Y Arnold, Linda T Nieman, Jonathan H Chen, Thomas Eisenhaure, Karin Pelka, Yuhui Song, Katherine H Xu, Vjola Jorgji, Christopher J Pinto, Tatyana Sharova, Rachel Glasser, PuiYee Chan, Ryan J Sullivan, Hamed Khalili, Dejan Juric, Genevieve Marie Boland, Michael Dougan, Nir Hacohen, Bo Li, Kerry L Reynolds, Alexandra-Chloé Villani
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis. Nature medicine (2024)
Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner, Amina Bougrine, Leeann Burton, Laura C Cappelli, Mariana Castells, Justine Cohen, Anna K Dewan, Riley Fadden, Lauren Guggina, Aparna Hegde, Victor Huang, Douglas B Johnson, Benjamin Kaffenberger, Daniela Kroshinsky, Shawn Kwatra, Bernice Kwong, Mario E Lacouture, Cecilia Larocca, Jonathan Leventhal, Alina Markova, Jon McDunn, Meghan J Mooradian, Jarushka Naidoo, Jennifer Choi, Vinod Nambudiri, Caroline A Nelson, Anisha B Patel, Julia Pimkina, Johnathan Rine, Krista M Rubin, Maxwell Sauder, Sheila Shaigany, Afreen Shariff, Ryan J Sullivan, Leyre Zubiri, Kerry Lynn Reynolds, Nicole R LeBoeuf
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy. Journal for immunotherapy of cancer 12 (4) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Steven T Chen, Yevgeniy R Semenov, Allireza Alloo, Daniel Q Bach, Allison Betof Warner, Amina Bougrine, Leeann Burton, Laura C Cappelli, Mariana Castells, Justine Cohen, Anna K Dewan, Riley Fadden, Lauren Guggina, Aparna Hegde, Victor Huang, Douglas B Johnson, Benjamin Kaffenberger, Daniela Kroshinsky, Shawn Kwatra, Bernice Kwong, Mario E Lacouture, Cecilia Larocca, Jonathan Leventhal, Alina Markova, Jon McDunn, Meghan J Mooradian, Jarushka Naidoo, Jennifer Choi, Vinod Nambudiri, Caroline A Nelson, Anisha B Patel, Julia Pimkina, Johnathan Rine, Krista M Rubin, Maxwell Sauder, Sheila Shaigany, Afreen Shariff, Ryan J Sullivan, Leyre Zubiri, Kerry Lynn Reynolds, Nicole R LeBoeuf
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy. Journal for immunotherapy of cancer 12 (4) (2024)
Mary C Boulanger, Ayo S Falade, Kelly Hsu, Robert K Sommer, Ashley Zhou, Roshni Sarathy, Donald Lawrence, Ryan J Sullivan, Lara N Traeger, Joseph Andrew Greer, Jennifer S Temel, Laura A Petrillo
Patient and Caregiver Experience With the Hope and Prognostic Uncertainty of Immunotherapy: A Qualitative Study. JCO oncology practice (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase 1/2 study of combined BCL-xL and MEK inhibition with navitoclax and trametinib in KRAS or NRAS mutant advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, Julie Simon, Aikaterini Dedeilia, Sydney Ch'ng, Robyn P M Saw, Andrew J Spillane, Kerwin F Shannon, Thomas E Pennington, Michael Rtshiladze, Jonathan R Stretch, Omgo E Nieweg, Alexander C J van Akkooi, Ryan J Sullivan, Genevieve Marie Boland, Jeffrey E Gershenwald, Paul J van Diest, Richard A Scolyer, Georgina V Long, John F Thompson, Serigne N Lô
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Ryan B Corcoran, Khanh T Do, Jeong Eun Kim, James M Cleary, Aparna Raj Parikh, Oladapo O Yeku, Niya Xiong, Colin D Weekes, Jennifer T Veneris, Leanne G Ahronian, Gianluca Mauri, Jun Tian, Bryanna L Norden, Alexa G Michel, Emily E Van Seventer, Giulia Siravegna, Kyle Camphausen, Gary Chi, Isobel J Fetter, Joan S Brugge, Helen X Chen, Naoko Takebe, Richard T Penson, Dejan Juric, Keith T Flaherty, Ryan J Sullivan, Jeffrey W Clark, Rebecca S Heist, Ursula A Matulonis, Joyce F Liu, Geoffrey I Shapiro
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (9) (2024)
Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery 14 (7) (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II study of ERK inhibition by ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II study of ERK inhibition by ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications (2024)
Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery 14 (7) (2024)
Isabella C Glitza Oliva, Yongwoo David Seo, Christine N Spencer, Jennifer R Wortman, Elizabeth M Burton, Farah A Alayli, Christopher P Loo, Shikha Gautam, Ashish V Damania, Julie Densmore, Justin Fairchild, Christopher R Cabanski, Matthew C Wong, Christine B Peterson, Brian Weiner, Nathan D Hicks, John G Auniņš, Christopher McChalicher, Emily Walsh, Michael T Tetzlaff, Omid Hamid, Patrick A Ott, Genevieve Marie Boland, Ryan J Sullivan, Kenneth F Grossmann, Nadim J Ajami, Theresa M LaVallee, Matthew R Henn, Hussein A Tawbi, Jennifer A Wargo
Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer discovery 14 (7) (2024)
Elizabeth I Buchbinder, Justine V Cohen, Giuseppe Tarantino, Christine G Lian, David R Liu, Rizwan Haq, Frank Stephen Hodi, Donald P Lawrence, Anita Giobbie-Hurder, Deborah Knoerzer, Ryan J Sullivan
A Phase II Study of ERK Inhibition by Ulixertinib (BVD-523) in Metastatic Uveal Melanoma. Cancer research communications 4 (5) (2024)
Takuto Sato, Kamaneh Montazeri, Evangelos S Gragoudas, Anne Marie Lane, Mary Beth Aronow, Justine V Cohen, Genevieve Marie Boland, Eric Banks, Christopher Kachulis, Mark Fleharty, Carrie Cibulskis, Aleigha Lawless, Viktor A Adalsteinsson, Ryan J Sullivan, Ivana K Kim
Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma. JCO precision oncology 8 (2024)
Meghan J Mooradian, Florian J Fintelmann, Thomas J LaSalle, Judit Simon, Alexander Graur, Alona Muzikansky, Mari Mino-Kenudson, Sophia Z Shalhout, Howard L Kaufman, Russell William Jenkins, Donald Lawrence, Aleigha Lawless, Tatyana Sharova, Raul N Uppot, Jacy Fang, Emily M Blaum, Anna L K Gonye, Irena Gushterova, Genevieve Marie Boland, Christopher Azzoli, Nir Hacohen, Moshe Sade-Feldman, Ryan J Sullivan
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial. Nature communications 15 (1) (2024)
Molly Fisher Thomas, Kamil Slowikowski, Kasidet Manakongtreecheep, Pritha Sen, Nandini Samanta, Jessica Tantivit, Mazen Nasrallah, Leyre Zubiri, Neal P Smith, Alice Tirard, Swetha Ramesh, Benjamin Y Arnold, Linda T Nieman, Jonathan H Chen, Thomas Eisenhaure, Karin Pelka, Yuhui Song, Katherine H Xu, Vjola Jorgji, Christopher J Pinto, Tatyana Sharova, Rachel Glasser, PuiYee Chan, Ryan J Sullivan, Hamed Khalili, Dejan Juric, Genevieve Marie Boland, Michael Dougan, Nir Hacohen, Bo Li, Kerry L Reynolds, Alexandra-Chloé Villani
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis. Nature medicine 30 (5) (2024)
Naiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, Helen X Chen, Robert L Ferris, Sarah B Goldberg, Matthew D Hellmann, Ranee Mehra, Ina Rhee, Jong Chul Park, Harriet M Kluger, Hussein A Tawbi, Ryan J Sullivan
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy. Journal for immunotherapy of cancer 11 (3) (2023)
Meghan J Mooradian, Ryan J Sullivan
The case for adjuvant BRAF-targeted therapy versus adjuvant anti-PD-1 therapy for patients with resected, high-risk melanoma. Cancer 129 (14) (2023)
Meghan E Sise, Qiyu Wang, Harish Seethapathy, Daiana Moreno, Destiny Harden, R Neal Smith, Ivy A Rosales, Robert B Colvin, Sarah Chute, Lynn D Cornell, Sandra M Herrmann, Riley Fadden, Ryan J Sullivan, Nancy J Yang, Sara Barmettler, Sophia Wells, Shruti Gupta, Alexandra-Chloe Villani, Kerry Lynn Reynolds, Jocelyn Farmer
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis. Journal for immunotherapy of cancer 11 (1) (2023)
Meghan E Sise, Qiyu Wang, Harish Seethapathy, Daiana Moreno, Destiny Harden, R Neal Smith, Ivy A Rosales, Robert B Colvin, Sarah Chute, Lynn D Cornell, Sandra M Herrmann, Riley Fadden, Ryan J Sullivan, Nancy J Yang, Sara Barmettler, Sophia Wells, Shruti Gupta, Alexandra-Chloe Villani, Kerry Lynn Reynolds, Jocelyn Farmer
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis. Journal for immunotherapy of cancer 11 (1) (2023)
Michael B Atkins, Paolo Antonio Ascierto, David Feltquate, James L Gulley, Douglas B Johnson, Nikhil I Khushalani, Jeffrey Sosman, Timonthy A Yap, Harriet M Kluger, Ryan J Sullivan, Hussein A Tawbi
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies. Journal for immunotherapy of cancer 11 (3) (2023)
David S Hong, Michael A Postow, Bartosz Chmielowski, Ryan J Sullivan, Amita Patnaik, Ezra E W Cohen, Geoffrey I Shapiro, Conor E Steuer, Martin Gutierrez, Heather Yeckes-Rodin, Robert Ilaria, Brenda C O'Connell, Joanna Peng, Guangbin Peng, Nora Zizlsperger, Anthony W Tolcher, Jedd D Wolchok
Eganelisib, a First-in-Class PI3K-γ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Harriet M Kluger, J Carl Barrett, Justin F Gainor, Omid Hamid, Michael Hurwitz, Theresa LaVallee, Rebecca A Moss, Roberta Zappasodi, Ryan J Sullivan, Hussein A Tawbi, Elad Sharon
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors. Journal for immunotherapy of cancer 11 (3) (2023)
Tian Zhang, Patrick M Forde, Ryan J Sullivan, Elad Sharon, Elizabeth Barksdale, Wendy Selig, Scot Ebbinghaus, Gina Fusaro, Damla Gunenc, Dena Battle, Robyn Burns, Marc S Hurlbert, Mark Stewart, Michael B Atkins
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs. Journal for immunotherapy of cancer 11 (5) (2023)
Harriet M Kluger, Hussein A Tawbi, David Feltquate, Theresa LaVallee, Naiyer A Rizvi, Elad Sharon, Jeffrey Sosman, Ryan J Sullivan
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development. Journal for immunotherapy of cancer 11 (7) (2023)
Meghan E Sise, Qiyu Wang, Harish Seethapathy, Daiana Moreno, Destiny Harden, R Neal Smith, Ivy A Rosales, Robert B Colvin, Sarah Chute, Lynn D Cornell, Sandra M Herrmann, Riley Fadden, Ryan J Sullivan, Nancy J Yang, Sara Barmettler, Sophia Wells, Shruti Gupta, Alexandra-Chloe Villani, Kerry Lynn Reynolds, Jocelyn Farmer
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis. Journal for immunotherapy of cancer 11 (1) (2023)
Meghan E Sise, Qiyu Wang, Harish Seethapathy, Daiana Moreno, Destiny Harden, R Neal Smith, Ivy A Rosales, Robert B Colvin, Sarah Chute, Lynn D Cornell, Sandra M Herrmann, Riley Fadden, Ryan J Sullivan, Nancy J Yang, Sara Barmettler, Sophia Wells, Shruti Gupta, Alexandra-Chloe Villani, Kerry Lynn Reynolds, Jocelyn Farmer
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis. Journal for immunotherapy of cancer 11 (1) (2023)
Naiyer Rizvi, Foluso O Ademuyiwa, Z Alexander Cao, Helen X Chen, Robert L Ferris, Sarah B Goldberg, Matthew D Hellmann, Ranee Mehra, Ina Rhee, Jong Chul Park, Harriet M Kluger, Hussein A Tawbi, Ryan J Sullivan
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with chemotherapy. Journal for immunotherapy of cancer 11 (3) (2023)
Paul B Chapman, Mark G Klang, Michael A Postow, Alexander N Shoushtari, Ryan J Sullivan, Jedd D Wolchok, Taha Merghoub, Sadna Budhu, Phillip Wong, Margaret K Callahan, Bin Zheng, Jonathan H Zippin
Phase Ib trial of phenformin in patients with V600-mutated melanoma receiving dabrafenib and trametinib. Cancer research communications (2023)
Michael B Atkins, Paolo Antonio Ascierto, David Feltquate, James L Gulley, Douglas B Johnson, Nikhil I Khushalani, Jeffrey Sosman, Timonthy A Yap, Harriet M Kluger, Ryan J Sullivan, Hussein A Tawbi
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies. Journal for immunotherapy of cancer 11 (3) (2023)
Meghan J Mooradian, James M Cleary, Anita Giobbie-Hurder, Lancia N F Darville, Aparna Raj Parikh, Elizabeth I Buchbinder, Justine V Cohen, Donald P Lawrence, Geoffrey I Shapiro, Harold Keer, Helen X Chen, Susan Percy Ivy, Keiran S M Smalley, John M Koomen, Ryan J Sullivan
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors. Cancer (2023)
Tian Zhang, Patrick M Forde, Ryan J Sullivan, Elad Sharon, Elizabeth Barksdale, Wendy Selig, Scot Ebbinghaus, Gina Fusaro, Damla Gunenc, Dena Battle, Robyn Burns, Marc S Hurlbert, Mark Stewart, Michael B Atkins
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs. Journal for immunotherapy of cancer 11 (5) (2023)
Ryan J Sullivan
To Inhibit or Not to Inhibit MEK With BRAF Inhibitors: Is That the Question? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Meghan E Sise, Qiyu Wang, Harish Seethapathy, Daiana Moreno, Destiny Harden, R Neal Smith, Ivy A Rosales, Robert B Colvin, Sarah Chute, Lynn D Cornell, Sandra M Herrmann, Riley Fadden, Ryan J Sullivan, Nancy J Yang, Sara Barmettler, Sophia Wells, Shruti Gupta, Alexandra-Chloe Villani, Kerry Lynn Reynolds, Jocelyn Farmer
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis. Journal for immunotherapy of cancer 11 (1) (2023)
Anna C Pavlick, Charlotte E Ariyan, Elizabeth I Buchbinder, Diwakar Davar, Geoffrey Thomas Gibney, Omid Hamid, Tina J Hieken, Benjamin Izar, Douglas B Johnson, Rajan P Kulkarni, Jason John Luke, Tara C Mitchell, Meghan J Mooradian, Krista M Rubin, April Ks Salama, Keisuke Shirai, Janis M Taube, Hussein A Tawbi, J Keith Tolley, Caressa Valdueza, Sarah A Weiss, Michael K Wong, Ryan J Sullivan
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0. Journal for immunotherapy of cancer 11 (10) (2023)
Tian Zhang, Patrick M Forde, Ryan J Sullivan, Elad Sharon, Elizabeth Barksdale, Wendy Selig, Scot Ebbinghaus, Gina Fusaro, Damla Gunenc, Dena Battle, Robyn Burns, Marc S Hurlbert, Mark Stewart, Michael B Atkins
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs. Journal for immunotherapy of cancer 11 (5) (2023)
Priscilla Kaliopi Brastianos, Albert E Kim, Anita Giobbie-Hurder, Eudocia Q Lee, Nancy U Lin, Beth A Overmoyer, Patrick Y Wen, Lakshmi Nayak, Justine V Cohen, Jorg Dietrich, April Eichler, Rebecca S Heist, Ian Krop, Donald Lawrence, Jennifer Ligibel, Sara M Tolaney, Erica L Mayer, Eric Winer, Brittany Bent, Magali A de Sauvage, Nazanin Ijad, Juliana M Larson, Braxton Marion, Sally Nason, Naina Murthy, Sherry Ratcliff, Elizabeth J Summers, Maura Mahar, Helen A Shih, Kevin Oh, Daniel P Cahill, Elizabeth R Gerstner, Ryan J Sullivan
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results. Nature medicine (2023)
Harriet M Kluger, J Carl Barrett, Justin F Gainor, Omid Hamid, Michael Hurwitz, Theresa LaVallee, Rebecca A Moss, Roberta Zappasodi, Ryan J Sullivan, Hussein A Tawbi, Elad Sharon
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors. Journal for immunotherapy of cancer 11 (3) (2023)
Patrick A Ott, Matthew Nazzaro, Kathleen L Pfaff, Evisa Gjini, Kristen D Felt, Jacquelyn O Wolff, Elizabeth I Buchbinder, Rizwan Haq, Ryan J Sullivan, Donald P Lawrence, David F McDermott, Mariano Severgnini, Anita Giobbie-Hurder, Scott J Rodig, F Stephen Hodi
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial. Journal for immunotherapy of cancer 9 (11) (2022)
Ryan J Sullivan
What, if Any, Role Is There for BRAF-Targeted Therapy in BRAF -Mutant Melanoma? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Leyre Zubiri, Gabriel E Molina, Meghan J Mooradian, Justine Cohen, Sienna M Durbin, Laura Petrillo, Genevieve M Boland, Dejan Juric, Michael L Dougan, Molly F Thomas, Alex T Faje, Michelle Rengarajan, Amanda C Guidon, Steven T Chen, Daniel Okin, Benjamin D Medoff, Mazen Nasrallah, Minna J Kohler, Sara R Schoenfeld, Rebecca S Karp-Leaf, Meghan E Sise, Tomas G Neilan, Daniel A Zlotoff, Jocelyn R Farmer, Aditya Bardia, Ryan J Sullivan, Steven M Blum, Yevgeniy R Semenov, Alexandra-Chloé Villani, Kerry L Reynolds
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer. Journal for immunotherapy of cancer 9 (9) (2022)
Ryan J Sullivan
For Whom the Bell Tolls? A Toll-Like Receptor 9 Agonist's Journey from Vaccine Adjuvant to Promising Agent in Anti-PD-1-Resistant Melanoma. Cancer discovery 11 (12) (2022)
Bruce C Tiu, Leyre Zubiri, James Iheke, Vartan Pahalyants, Nicholas Theodosakis, Pearl Ugwu-Dike, Jayhyun Seo, Kimberly Tang, Meghan E Sise, Ryan J Sullivan, Jarushka Naidoo, Meghan J Mooradian, Yevgeniy R Semenov, Kerry Lynn Reynolds
Real-world incidence and impact of pneumonitis in patients with lung cancer treated with immune checkpoint inhibitors: a multi-institutional cohort study. Journal for immunotherapy of cancer 10 (6) (2022)
Briana Rose Halle, Allison Betof Warner, Farzana Y Zaman, Andrew Haydon, Prachi Bhave, Anna K Dewan, Fei Ye, Rebecca Irlmeier, Paras Mehta, Nicholas R Kurtansky, Mario E Lacouture, Jessica C Hassel, Jacob S Choi, Jeffrey A Sosman, Sunandana Chandra, Tracey S Otto, Ryan J Sullivan, Meghan J Mooradian, Steven T Chen, Florentia Dimitriou, Georgina Long, Matteo Carlino, Alexander Menzies, Douglas B Johnson, Veronica M Rotemberg
Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy. Journal for immunotherapy of cancer 9 (10) (2022)
Zhaowei Chu, Lei Gu, Yeguang Hu, Xiaoyang Zhang, Man Li, Jiajia Chen, Da Teng, Man Huang, Che-Hung Shen, Li Cai, Yeguang Hu, Yifeng Qi, Zhixin Niu, Austin Feng, Songmei Geng, Dennie T Frederick, Emma Specht, Adriano Piris, Ryan J Sullivan, Keith T Flaherty, Genevieve M Boland, Katia Georgopoulos, David Liu, Yang Shi, Bin Zheng
STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming. Nature communications 13 (1) (2022)
Jingyi Gong, Zsofia Dora Drobni, Amna Zafar, Thiago Quinaglia, Sarah Hartmann, Hannah K Gilman, Vineet K Raghu, Carlos Gongora, Meghan E Sise, Raza M Alvi, Leyre Zubiri, Anju Nohria, Ryan J Sullivan, Kerry L Reynolds, Daniel A Zlotoff, Tomas G Neilan
Pericardial disease in patients treated with immune checkpoint inhibitors. Journal for immunotherapy of cancer 9 (6) (2022)
Poulikos I Poulikakos, Ryan J Sullivan, Rona Yaeger
Molecular Pathways and Mechanisms of BRAF in Cancer Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Thomas S C Ng, Hui-Yu Hu, Stefan Kronister, Chanseo Lee, Ran Li, Luca Gerosa, Sylwia A Stopka, Danielle M Burgenske, Ishaan Khurana, Michael S Regan, Sreeram Vallabhaneni, Niharika Putta, Ella Scott, Dylan Matvey, Anita Giobbie-Hurder, Rainer H Kohler, Jann N Sarkaria, Sareh Parangi, Peter Karl Sorger, Nathalie Y R Agar, Heather A Jacene, Ryan J Sullivan, Elizabeth Buchbinder, Hannes Mikula, Ralph Weissleder, Miles A Miller
Overcoming differential tumor penetration of BRAF inhibitors using computationally guided combination therapy. Science advances 8 (17) (2022)
Carlos Gomez-Roca, Philippe Cassier, Dmitriy Zamarin, Jean-Pascal H Machiels, Jose Luis Perez Gracia, F Stephen Hodi, Alvaro Taus, Maria Martinez Garcia, Valentina Boni, Joseph P Eder, Navid Hafez, Ryan J Sullivan, David Mcdermott, Stephane Champiat, Sandrine Aspeslagh, Catherine Terret, Anna-Maria Jegg, Wolfgang Jacob, Michael A Cannarile, Carola Ries, Konstanty Korski, Francesca Michielin, Randolph Christen, Galina Babitzki, Carl Watson, Georgina Meneses-Lorente, Martin Weisser, Dominik Rüttinger, Jean-Pierre Delord, Aurélien Marabelle
Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade. Journal for immunotherapy of cancer 10 (5) (2022)
Matthew Dankner, Yifan Wang, Rouhi Fazelzad, Benny Johnson, Caroline A Nebhan, Ibiayi Dagogo-Jack, Nathaniel J Myall, Georg Richtig, Jillian Wilhelmina Paulina Bracht, Marco Gerlinger, Eiji Shinozaki, Takayuki Yoshino, Daisuke Kotani, Jason R Fangusaro, Oliver Gautschi, Julien Mazieres, Jeffrey A Sosman, Edmund S Kopetz, Vivek Subbiah, Michael A Davies, Anna L Groover, Ryan J Sullivan, Keith T Flaherty, Douglas B Johnson, Andrea Benedetti, David W Cescon, Anna Spreafico, George Zogopoulos, April A N Rose
Clinical Activity of Mitogen-Activated Protein Kinase-Targeted Therapies in Patients With Non-V600 BRAF-Mutant Tumors. JCO precision oncology 6 (2022)
Prachi Bhave, Tasnia Ahmed, Serigne N Lô, Alexander N Shoushtari, Anne Zaremba, Judith M Versluis, Joanna Mangana, Michael Weichenthal, Lu Si, Thierry Lesimple, Caroline Robert, Claudia Trojanello, Alexandre Wicky, Richard Heywood, Lena Tran, Kathleen Batty, Florentia Dimitriou, Anna Stansfeld, Clara Allayous, Julia Katharina Schwarze, Meghan J Mooradian, Oliver Klein, Inderjit Mehmi, Rachel Roberts-Thomson, Andrea Maurichi, Hui-Ling Yeoh, Adnan Khattak, Lisa Zimmer, Christian U Blank, Egle Ramelyte, Katharina C Kähler, Severine Roy, Paolo Antonio Ascierto, Olivier Michielin, Paul C Lorigan, Douglas B Johnson, Ruth Plummer, Celeste Lebbe, Bart Neyns, Ryan J Sullivan, Omid Hamid, Mario Santinami, Grant A McArthur, Andrew M Haydon, Georgina V Long, Alexander M Menzies, Matteo S Carlino
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma. Journal for immunotherapy of cancer 10 (7) (2022)
Christopher Alvarez-Breckenridge, Samuel C Markson, Jackson H Stocking, Naema Nayyar, Matt Lastrapes, Matthew R Strickland, Albert E Kim, Magali A de Sauvage, Ashish Dahal, Juliana M Larson, Joana Liliana Mora, Andrew W Navia, Robert H Klein, Benjamin M Kuter, Corey M Gill, Mia S Bertalan, Brian Shaw, Alexander Kaplan, Megha Subramanian, Aarushi Jain, Swaminathan Kumar, Husain H Danish, Michael D White, Osmaan Shahid, Kristen E Pauken, Brian C Miller, Dennie T Frederick, Christine Hebert, McKenzie L Shaw, Maria Martinez-Lage, Matthew P Frosch, Nancy Wang, Elizabeth R Gerstner, Brian Vala Nahed, William T Curry, Bob S Carter, Daniel P Cahill, Genevieve Marie Boland, Benjamin Izar, Michael A Davies, Arlene H Sharpe, Mario L Suvà, Ryan J Sullivan, Priscilla Kaliopi Brastianos, Scott L Carter
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition. Cancer immunology research 10 (8) (2022)
Dirk Schadendorf, Reinhard Dummer, Caroline Robert, Antoni Ribas, Ryan J Sullivan, Timothy Panella, Meredith A McKean, Edgardo S Santos, Kimberli Brill, Anna Polli, Alessandra di Pietro, Paolo Antonio Ascierto
STARBOARD: encorafenib + binimetinib + pembrolizumab for first-line metastatic/unresectable BRAF V600-mutant melanoma. Future oncology (London, England) 18 (17) (2022)
Priscilla Kaliopi Brastianos, Albert E Kim, Nancy Wang, Eudocia Q Lee, Jennifer Ligibel, Justine V Cohen, Ugonma N Chukwueke, Maura Mahar, Kevin Oh, Michael D White, Helen A Shih, Deborah Forst, Justin F Gainor, Rebecca S Heist, Elizabeth R Gerstner, Tracy T Batchelor, Donald Lawrence, David P Ryan, A John Iafrate, Anita Giobbie-Hurder, Sandro Santagata, Scott L Carter, Daniel P Cahill, Ryan J Sullivan
Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterations. Nature cancer 2 (5) (2021)
Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Teilo H Schaller, Anthony A Amato, Allison Betof Warner, Priscilla K Brastianos, Tracey A Cho, Stacey L Clardy, Justine V Cohen, Jorg Dietrich, Michael L Dougan, Christopher T Doughty, Divyanshu Dubey, Jeffrey M Gelfand, Jeffrey T Guptill, Douglas B Johnson, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Jenny Linnoila, Andrew L Mammen, Maria Martinez-Lage, Meghan J Mooradian, Jarushka Naidoo, Tomas G Neilan, David A Reardon, Krista M Rubin, Bianca D Santomasso, Ryan J Sullivan, Nancy Wang, Karin Woodman, Leyre Zubiri, William C Louv, Kerry L Reynolds
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors. Journal for immunotherapy of cancer 9 (7) (2021)
Sanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, Albert E Kim, Robert H Klein, Naema Nayyar, Andrew W Navia, Benjamin M Kuter, Kellie E Kolb, Ivanna Bihun, Joana Liliana Mora, Mia Solana Bertalan, Brian Shaw, Michael D White, Alexander Kaplan, Jackson H Stocking, Marc H Wadsworth, Eudocia Q Lee, Ugonma Chukwueke, Nancy Wang, Megha Subramanian, Denisse Rotem, Daniel P Cahill, Viktor A Adalsteinsson, Jeffrey W Miller, Ryan J Sullivan, Scott L Carter, Priscilla Kaliopi Brastianos, Alex K Shalek
Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases. Nature communications 12 (1) (2021)
James M Cleary, Srivatsan Raghavan, Qibiao Wu, Yvonne Y Li, Liam F Spurr, Hersh V Gupta, Douglas A Rubinson, Isobel J Fetter, Jason L Hornick, Jonathan A Nowak, Giulia Siravegna, Lipika Goyal, Lei Shi, Lauren K Brais, Maureen Loftus, Atul B Shinagare, Thomas A Abrams, Thomas E Clancy, Jiping Wang, Anuj K Patel, Franck Brichory, Anne Vaslin Chessex, Ryan J Sullivan, Rachel B Keller, Sarah Denning, Emma R Hill, Geoffrey I Shapiro, Anna Pokorska-Bocci, Claudio Zanna, Kimmie Ng, Deborah Schrag, Pasi A Jänne, William C Hahn, Andrew D Cherniack, Ryan B Corcoran, Matthew Meyerson, Antoine Daina, Vincent Zoete, Nabeel Bardeesy, Brian M Wolpin
FGFR2 Extracellular Domain In-Frame Deletions Are Therapeutically Targetable Genomic Alterations That Function as Oncogenic Drivers in Cholangiocarcinoma. Cancer discovery 11 (10) (2021)
Priscilla K Brastianos, Matthew R Strickland, Eudocia Quant Lee, Nancy Wang, Justine V Cohen, Ugonma Chukwueke, Deborah Anne Forst, April Eichler, Beth Overmoyer, Nancy U Lin, Wendy Y Chen, Aditya Bardia, Dejan Juric, Ibiayi Dagogo-Jack, Michael D White, Jorg Dietrich, Naema Nayyar, Albert E Kim, Christopher Alvarez-Breckenridge, Maura Mahar, Joana Liliana Mora, Brian V Nahed, Pamela S Jones, Helen A Shih, Elizabeth R Gerstner, Anita Giobbie-Hurder, Scott L Carter, Kevin Oh, Daniel P Cahill, Ryan J Sullivan
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis. Nature communications 12 (1) (2021)
Lauren B Banks, Ryan J Sullivan
When is it OK to Stop Anti-Programmed Death 1 Receptor (PD-1) Therapy in Metastatic Melanoma? American journal of clinical dermatology 21 (3) (2021)
Kuang Du, Shiyou Wei, Zhi Wei, Dennie T Frederick, Benchun Miao, Tabea Moll, Tian Tian, Eric Sugarman, Dmitry I Gabrilovich, Ryan J Sullivan, Lun-Xu Liu, Keith T Flaherty, Genevieve Marie Boland, Meenhard Herylyn, Gao Zhang
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma. Nature communications 12 (1) (2021)
Sanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, Albert E Kim, Robert H Klein, Naema Nayyar, Andrew W Navia, Benjamin M Kuter, Kellie E Kolb, Ivanna Bihun, Joana Liliana Mora, Mia Solana Bertalan, Brian Shaw, Michael D White, Alexander Kaplan, Jackson H Stocking, Marc H Wadsworth, Eudocia Q Lee, Ugonma Chukwueke, Nancy Wang, Megha Subramanian, Denisse Rotem, Daniel P Cahill, Viktor A Adalsteinsson, Jeffrey W Miller, Ryan J Sullivan, Scott L Carter, Priscilla Kaliopi Brastianos, Alex K Shalek
Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases. Nature communications 12 (1) (2021)
Xue Bai, Jiani Hu, Allison Betof Warner, Henry T Quach, Christopher G Cann, Michael Z Zhang, Lu Si, Bixia Tang, Chuanliang Cui, Xiaoling Yang, Xiaoting Wei, Lalit Pallan, Catriona Harvey, Michael P Manos, Olivia Ouyang, Michelle S Kim, Gyulnara Kasumova, Justine V Cohen, Donald P Lawrence, Christine Freedman, Riley M Fadden, Krista M Rubin, Tatyana Sharova, Dennie T Frederick, Keith T Flaherty, Osama E Rahma, Georgina V Long, Alexander M Menzies, Jun Guo, Alexander N Shoushtari, Douglas B Johnson, Ryan J Sullivan, Genevieve Marie Boland
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
David Liu, Jia-Ren Lin, Emily J Robitschek, Gyulnara G Kasumova, Alex Heyde, Alvin Shi, Adam Kraya, Gao Zhang, Tabea Moll, Dennie T Frederick, Yu-An Chen, Shu Wang, Denis Schapiro, Li-Lun Ho, Kevin Bi, Avinash Sahu, Shaolin Mei, Benchun Miao, Tatyana Sharova, Christopher Alvarez-Breckenridge, Jackson H Stocking, Tommy Kim, Riley Fadden, Donald Lawrence, Mai P Hoang, Daniel P Cahill, Mohsen Malehmir, Martin A Nowak, Priscilla Kaliopi Brastianos, Christine G Lian, Eytan Ruppin, Benjamin Izar, Meenhard Herylyn, Eliezer Van Allen, Katherine L Nathanson, Keith T Flaherty, Ryan J Sullivan, Manolis Kellis, Peter Karl Sorger, Genevieve Marie Boland
Evolution of delayed resistance to immunotherapy in a melanoma responder. Nature medicine 27 (6) (2021)
Erik B Schiferle, Se Yun Cheon, Seokjin Ham, Heehwa G Son, Jonathan L Messerschmidt, Donald P Lawrence, Justine V Cohen, Keith T Flaherty, James J Moon, Christine G Lian, Ryan J Sullivan, Shadhmer Demehri
Rejection of benign melanocytic nevi by nevus-resident CD4+ T cells. Science advances 7 (26) (2021)
Vivek Naranbhai, Claire A Pernat, Alexander Gavralidis, Kerri J St Denis, Evan C Lam, Laura M Spring, Steven Jay Isakoff, Jocelyn R Farmer, Leyre Zubiri, Gabriela S Hobbs, Joan How, Andrew M Brunner, Amir T Fathi, Jennifer L Peterson, Mustafa Sakhi, Grace Hambelton, Elyssa N Denault, Lindsey J Mortensen, Lailoo A Perriello, Marissa N Bruno, Brittany Y Bertaux, Aleigha R Lawless, Monica A Jackson, Elizabeth Niehoff, Caroline Barabell, Christian N Nambu, Erika Nakajima, Trenton Reinicke, Cynthia Bowes, Cristhian J Berrios-Mairena, Onosereme Ofoman, Grace E Kirkpatrick, Julia C Thierauf, Kerry Lynn Reynolds, Henning Willers, Wilfredo-Garcia Beltran, Anand S Dighe, Rebecca R Saff, Kimberly G Blumenthal, Ryan J Sullivan, Yi-Bin Chen, Arthur Y Kim, Aditya Bardia, Alejandro B Balazs, A John Iafrate, Justin F Gainor
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Sonali M Smith, Kerri Wachter, Howard A Burris, Richard L Schilsky, Daniel J George, Douglas E Peterson, Melissa L Johnson, Merry Jennifer Markham, Kathryn F Mileham, Muhammad Shaalan Beg, Johanna C Bendell, Robert Dreicer, Vicki L Keedy, Randall J Kimple, Miriam A Knoll, Noelle K LoConte, Helen MacKay, Jane Lowe Meisel, Timothy J Moynihan, Daniel A Mulrooney, Therese Marie Mulvey, Olatoyosi Odenike, Nathan A Pennell, Katherine E Reeder-Hayes, Cardinale B Smith, Ryan J Sullivan, Robert Uzzo
Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (10) (2021)
Meghan D Lee, Harish Seethapathy, Ian A Strohbehn, Sophia H Zhao, Genevieve M Boland, Riley Fadden, Ryan J Sullivan, Kerry L Reynolds, Meghan E Sise
Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study. Journal for immunotherapy of cancer 9 (4) (2021)
Priscilla Kaliopi Brastianos, Eudocia Quant Lee, Justine V Cohen, Sara M Tolaney, Nancy U Lin, Nancy Wang, Ugonma Chukwueke, Michael D White, Naema Nayyar, Albert Kim, Christopher Alvarez-Breckenridge, Ian Krop, Maura Keeley Mahar, Mia S Bertalan, Brian Shaw, Joana L Mora, Nathaniel Goss, Megha Subramanian, Lakshmi Nayak, Jorg Dietrich, Deborah A Forst, Brian V Nahed, Tracy T Batchelor, Helen A Shih, Elizabeth R Gerstner, Beverly Moy, Donald Lawrence, Anita Giobbie-Hurder, Scott L Carter, Kevin Oh, Daniel P Cahill, Ryan J Sullivan
Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nature medicine 26 (8) (2020)
Alvin H Shi, Gyulnara G Kasumova, William A Michaud, Jessica Cintolo-Gonzalez, Marta Díaz-Martínez, Jacqueline Ohmura, Arnav Mehta, Isabel Chien, Dennie T Frederick, Sonia Cohen, Deborah Plana, Douglas Johnson, Keith T Flaherty, Ryan J Sullivan, Manolis Kellis, Genevieve Marie Boland
Plasma-derived extracellular vesicle analysis and deconvolution enable prediction and tracking of melanoma checkpoint blockade outcome. Science advances 6 (46) (2020)
Vivek Verma, Rajeev K Shrimali, Shamim Ahmad, Winjie Dai, Hua Wang, Sumin Lu, Rahul Nandre, Pankaj Gaur, Jose Lopez, Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, Keith T Flaherty, Jennifer A Wargo, Genevieve M Boland, Ryan J Sullivan, Gad A Getz, Scott A Hammond, Ming Tan, Jingjing Qi, Phillip Wong, Taha Merghoub, Jedd D Wolchok, Nir Hacohen, John E Janik, Mikayel Mkrtichyan, Seema Gupta, Samir N Khleif
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance. Nature immunology 20 (9) (2019)
Ryan J Sullivan, Omid Hamid, Rene Gonzalez, Jeffrey R Infante, Manish R Patel, F Stephen Hodi, Karl D Lewis, Hussein A Tawbi, Genevive Hernandez, Matthew J Wongchenko, YiMeng Chang, Louise Roberts, Marcus Ballinger, Yibing Yan, Edward Cha, Patrick Hwu
Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients. Nature medicine 25 (6) (2019)